Status:
COMPLETED
Can We Predict Who Has Gastroesophageal Reflux Disease (GERD)?
Lead Sponsor:
Vanderbilt University
Conditions:
Gastroesophageal Reflux Disease
Eligibility:
All Genders
18+ years
Brief Summary
Gastroesophageal reflux disease (GERD) is currently defined as "a condition which develops when the reflux of stomach contents causes troublesome symptoms and/or complications". Doctors often diagnose...
Eligibility Criteria
Inclusion
- Male and female subjects ages 18 or older
- Presenting to the Vanderbilt GI outpatient clinic with symptoms of GERD
- Undergoing upper endoscopy and wireless pH monitoring (standard of care)
- Erosive disease: presence of esophageal mucosal injuries documented
- Non-erosive disease: normal esophagogastroduodenoscopy (EGD) with symptoms
- Control group: normal subjects without symptoms of GERD
Exclusion
- Anti-reflux therapy within 7 days prior to the pH study
- Previous neck, esophagus, or stomach surgery
- Major motility disorders
- Previous neck, esophagus, or stomach cancer or radiations
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
254 Patients enrolled
Trial Details
Trial ID
NCT01204931
Start Date
November 1 2010
End Date
June 1 2015
Last Update
January 20 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center GI Outpatient Clinic
Nashville, Tennessee, United States, 37232